Octreotide
Octreotide. Long-acting somatostatin analog that suppresses growth hormone and gut hormones.
How it works. Binds somatostatin receptors (mainly SSTR2 and SSTR5), suppressing growth hormone, IGF-1, insulin, glucagon and gut hormone release.
What the research supports. 2 graded claims. Strongest: Lowers GH and IGF-1 in acromegaly (strong).
Hormonal impact. Effects on Growth hormone, IGF-1, Insulin, Glucagon.
Side effects and interactions. 3 medication interactions listed. Serious: Gallstones.
Common forms. Available as Injection, Monthly depot injection, Oral capsule (Mycapssa).
Community. Experiences from people who have tried Octreotide. Anecdotes are not medical advice.
Octreotide. Long-acting somatostatin analog that suppresses growth hormone and gut hormones.
What it is
An eight-amino-acid ring peptide used for acromegaly, carcinoid syndrome and some types of gut bleeding. Available as injections, a monthly depot and an oral capsule.
Also called
How it works
Binds somatostatin receptors (mainly SSTR2 and SSTR5), suppressing growth hormone, IGF-1, insulin, glucagon and gut hormone release.
Pathways
- SSTR2 / SSTR5 agonism
- Growth hormone suppression
- Gut hormone suppression
Effects
- ↓Growth hormone and IGF-1 decreases
- ↓Hormone-driven diarrhea and flushing decreases
What the research supports
Strong: consistent results across large trials or meta-analyses. Moderate: several trials, mostly positive. Limited: small or mixed studies. Preclinical: animal or cell research only.
Hormonal impact
Side effects & interactions
Common side effects
- Loose stools
- Abdominal pain
- Injection-site pain
Serious
- Gallstones
- Slow heart rate
- Blood-sugar swings
Medication interactions
Lowers cyclosporine absorption.
Doses may need adjusting.
Added slowing of the heart rate.
Check any supplement–medication combination with your pharmacist before starting.
Common forms
- Injection
- Monthly depot injection
- Oral capsule (Mycapssa)
Discussion
Loading discussion…